If you've ever taken a generic form of medicine, chances are you've been a customer of Mylan (MYL). The company's portfolio of generics is north of 1,100. It also sells several branded drugs, while its pharmaceutical ingredients business serves customers across 150 countries and territories. Mylan's third-quarter results, announced Oct. 25, were strong. CEO Heather Bresch noted the company saw a return to revenue growth in the Europe, Middle East